David M. Goldstein
Direttore Tecnico/Scientifico/R&S presso PRINCIPIA BIOPHARMA INC.
Posizioni attive di David M. Goldstein
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PRINCIPIA BIOPHARMA INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2016 | - |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Direttore/Membro del Consiglio | 30/03/2021 | - |
Storia della carriera di David M. Goldstein
Precedenti posizioni note di David M. Goldstein
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/01/1994 | 01/01/2011 |
| Stanford University | Corporate Officer/Principal | - | - |
Formazione di David M. Goldstein
| Franklin & Marshall College | Undergraduate Degree |
| University of Virginia | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| Aziende private | 2 |
|---|---|
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- David M. Goldstein
- Esperienza
